Bellerophon to Present at the JMP Securities Life Sciences Conference

Home/Client News/Bellerophon to Present at the JMP Securities Life Sciences Conference

Bellerophon to Present at the JMP Securities Life Sciences Conference

WARREN, N.J., June 13, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the JMP Securities Life Sciences Conference, being held June 19-20, 2019, at the St. Regis New York Hotel in New York City.

By | 2019-06-13T15:17:05+00:00 June 13th, 2019|Client News|Comments Off on Bellerophon to Present at the JMP Securities Life Sciences Conference